Background & Aims The prevalence and significance of digestive manifestations in
coronavirus disease 2019 (COVID-19) remain uncertain. We aimed to assess the …

Introduction: Gastrointestinal (GI) symptoms are increasingly being recognized in
coronavirus disease 2019 (COVID-19). It is unclear if the presence of GI symptoms is …

METHODS: This is a retrospective review of consecutive patients diagnosed with COVID-19.
A total of 207 patients were identified; 34.5% of patients noted concurrent gastrointestinal …

Although not common, gastrointestinal and liver symptoms have reportedly been the initial
presentation of coronavirus disease‐2019 (COVID‐19) in a large group of patients …

OBJECTIVE: Since the outbreak of Coronavirus Disease 2019 (COVID-19) in December
2019, various digestive symptoms have been frequently reported in patients infected with …

Background & Aims Multiple gastrointestinal (GI) symptoms, including diarrhea,
nausea/vomiting, and abdominal pain, as well as liver enzyme abnormalities, have been …

Background The prevalence and prognosis of digestive system involvement, including
gastrointestinal symptoms and liver injury, in patients with COVID-19 remains largely …

Background: The worldwide outbreak of COVID-19 infected millions of people. Some
patients had gastrointestinal (GI) symptoms, abnormal liver function, digestive system …

METHODS: We performed a prospective single-center cohort study, enrolling patients who
received diagnosis of COVID-19 at our institution between March 23, 2020, and April 5 …

METHODS: Consecutive patients with COVID-19, diagnosed in a university hospital referral
laboratory in northern India, were evaluated for clinical manifestations including GI …